Novelion Therapeutics
€8.40
0
+€0.00+0%Friday 22:07
Statistics
Day High
1.68
Day Low
1.68
52W High
8.4
52W Low
1.68
Volume
0
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Novelion Therapeutics Inc., a biopharmaceutical company, develops a portfolio of therapies for individuals living with rare diseases. Its product portfolio includes MYALEPT for the treatment of generalized lipodystrophy; JUXTAPID for treating homozygous familial hypercholesterolemia (HoFH) in adults; and zuretinol acetate for the treatment of inherited retinal disease caused by underlying mutations in RPE65 or LRAT genes. The company also offers LOJUXTA (lomitapide) hard capsule for the treatment of HoFH in adults; and MYALEPT (metreleptin), a recombinant analogue of human leptin, indicated as an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with congenital or acquired generalized lipodystrophy. The company was formerly known as QLT Inc. and changed its name to Novelion Therapeutics Inc. in November 2016. Novelion Therapeutics Inc. was founded in 1981 and is headquartered in Vancouver, Canada.
Show More
CEO
Country
Germany
ISIN
CA67001K1030
Listings
0 Comments
Share your thoughts
FAQs
What is Novelion Therapeutics stock price today?▼
The current price of QLT.STU is €8.40 EUR — it has increased by +0% in the past 24 hours. Watch Novelion Therapeutics stock price performance more closely on the chart.
What is Novelion Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Stuttgart exchange Novelion Therapeutics stocks are traded under the ticker QLT.STU.
In which sector is Novelion Therapeutics located?▼
Novelion Therapeutics operates in the Materials sector.
When did Novelion Therapeutics complete a stock split?▼
The last stock split for Novelion Therapeutics was on December 21, 2016 with a ratio of 1:5.